• Je něco špatně v tomto záznamu ?

Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine analysis by an improved ELISA: An inter-laboratory comparison study

P. Rossner, H. Orhan, G. Koppen, K. Sakai, RM. Santella, A. Ambroz, A. Rossnerova, RJ. Sram, M. Ciganek, J. Neca, E. Arzuk, N. Mutlu, MS. Cooke,

. 2016 ; 95 (-) : 169-79. [pub] 20160322

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017322

ELISA is commonly used for the detection of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), a marker of whole body oxidative stress. However, the method has been criticized for high inter-laboratory variability and poor agreement with chromatographic techniques. We performed an inter-laboratory comparison of 8-oxodG assessed in 30 urine samples and a urine spiked with four different concentrations of 8-oxodG by ELISA using standardized experimental conditions, including: sample pre-treatment with solid-phase extraction (SPE), performing analysis using a commercial kit from a single manufacturer and strict temperature control during the assay. We further compared the ELISA results with high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) and performed tentative identification of compounds that may contribute to the discrepancy between both methods. For all but one participating laboratory (Data 1) we observed consistent ELISA results lying mostly within 1SD of the mean 8-oxodG concentration. Mean 8-oxodG levels assessed by ELISA correlated with the data obtained by HPLC-MS/MS (R=0.679, p<0.001). The correlation improved when Data 1 were excluded from the analysis (R=0.749, p<0.001). We identified three outlying urine samples; one with an ELISA 8-oxodG concentration lower, and two with 8-oxodG levels higher, than those measured by HPLC-MS/MS. Omitting these samples further improved inter-methodology agreement (R=0.869, p<0.001). In the outliers with high 8-oxodG estimates various aromatic and heterocyclic compounds were tentatively identified using gas chromatography-mass spectrometry (GC-MS). Application of authentic standards revealed the presence of saccharides, including d-glucose and d-galactose as putative interfering substances. In summary, assay standardization improved ELISA inter-laboratory agreement, although some variability is still observed. There are still compounds contributing to overestimation of 8-oxodG by ELISA, but only in some urine samples. Thus, despite significant improvement, ELISA still should not be considered a robust alternative to chromatographic techniques.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017322
003      
CZ-PrNML
005      
20180515103113.0
007      
ta
008      
180515s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.freeradbiomed.2016.03.016 $2 doi
035    __
$a (PubMed)27016072
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rossner, Pavel $u Department of Genetic Ecotoxicology, Institute of Experimental Medicine AS CR, Videnska 1083, 14220 Prague, Czech Republic. Electronic address: prossner@biomed.cas.cz.
245    10
$a Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine analysis by an improved ELISA: An inter-laboratory comparison study / $c P. Rossner, H. Orhan, G. Koppen, K. Sakai, RM. Santella, A. Ambroz, A. Rossnerova, RJ. Sram, M. Ciganek, J. Neca, E. Arzuk, N. Mutlu, MS. Cooke,
520    9_
$a ELISA is commonly used for the detection of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), a marker of whole body oxidative stress. However, the method has been criticized for high inter-laboratory variability and poor agreement with chromatographic techniques. We performed an inter-laboratory comparison of 8-oxodG assessed in 30 urine samples and a urine spiked with four different concentrations of 8-oxodG by ELISA using standardized experimental conditions, including: sample pre-treatment with solid-phase extraction (SPE), performing analysis using a commercial kit from a single manufacturer and strict temperature control during the assay. We further compared the ELISA results with high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) and performed tentative identification of compounds that may contribute to the discrepancy between both methods. For all but one participating laboratory (Data 1) we observed consistent ELISA results lying mostly within 1SD of the mean 8-oxodG concentration. Mean 8-oxodG levels assessed by ELISA correlated with the data obtained by HPLC-MS/MS (R=0.679, p<0.001). The correlation improved when Data 1 were excluded from the analysis (R=0.749, p<0.001). We identified three outlying urine samples; one with an ELISA 8-oxodG concentration lower, and two with 8-oxodG levels higher, than those measured by HPLC-MS/MS. Omitting these samples further improved inter-methodology agreement (R=0.869, p<0.001). In the outliers with high 8-oxodG estimates various aromatic and heterocyclic compounds were tentatively identified using gas chromatography-mass spectrometry (GC-MS). Application of authentic standards revealed the presence of saccharides, including d-glucose and d-galactose as putative interfering substances. In summary, assay standardization improved ELISA inter-laboratory agreement, although some variability is still observed. There are still compounds contributing to overestimation of 8-oxodG by ELISA, but only in some urine samples. Thus, despite significant improvement, ELISA still should not be considered a robust alternative to chromatographic techniques.
650    _2
$a biologické markery $x moč $7 D015415
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a deoxyguanosin $x analogy a deriváty $x moč $7 D003849
650    _2
$a ELISA $x metody $7 D004797
650    _2
$a lidé $7 D006801
650    _2
$a oxidační stres $x genetika $7 D018384
650    _2
$a extrakce na pevné fázi $7 D052616
650    _2
$a tandemová hmotnostní spektrometrie $7 D053719
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Orhan, Hilmi $u Ege University Faculty of Pharmacy, Department of Toxicology, Bornova-Izmir, Turkey.
700    1_
$a Koppen, Gudrun $u Flemish Institute for Technological Research (VITO), Environmental Risk and Health Unit, Mol, Antwerp, Belgium.
700    1_
$a Sakai, Kazuo $u Japan Institute for the Control of Aging (JaICA), Nikken SEIL Co., Fukuroi, Shizuoka, Japan.
700    1_
$a Santella, Regina M $u Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
700    1_
$a Ambroz, Antonin $u Department of Genetic Ecotoxicology, Institute of Experimental Medicine AS CR, Videnska 1083, 14220 Prague, Czech Republic.
700    1_
$a Rossnerova, Andrea $u Department of Genetic Ecotoxicology, Institute of Experimental Medicine AS CR, Videnska 1083, 14220 Prague, Czech Republic.
700    1_
$a Sram, Radim J $u Department of Genetic Ecotoxicology, Institute of Experimental Medicine AS CR, Videnska 1083, 14220 Prague, Czech Republic.
700    1_
$a Ciganek, Miroslav $u Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Neca, Jiri $u Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Arzuk, Ege $u Ege University Faculty of Pharmacy, Department of Toxicology, Bornova-Izmir, Turkey.
700    1_
$a Mutlu, Neliye $u Ege University Faculty of Pharmacy, Department of Toxicology, Bornova-Izmir, Turkey.
700    1_
$a Cooke, Marcus S $u Department of Environmental and Occupational Health, Florida International University, Miami, FL, USA.
773    0_
$w MED00001857 $t Free radical biology & medicine $x 1873-4596 $g Roč. 95, č. - (2016), s. 169-79
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27016072 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103246 $b ABA008
999    __
$a ok $b bmc $g 1300946 $s 1014162
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 95 $c - $d 169-79 $e 20160322 $i 1873-4596 $m Free radical biology & medicine $n Free Radic Biol Med $x MED00001857
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace